SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (4032)6/6/2001 12:10:26 PM
From: aknahow  Respond to of 52153
 
Looking for the name of a drug/biotech company that constructed a site for production of recombinants about a year ago but has been unable to obtain FDA validation. Any information, including reasons validation has been difficult to obtain would be appreciated.



To: Biomaven who wrote (4032)6/6/2001 12:15:42 PM
From: Michael Young  Read Replies (1) | Respond to of 52153
 
KOSP is really frustrating in many respects.

They have a drug that meets a significant need in a fast growing market. And they only need a relatively small percentage of that market to send the stock to MUCH higher levels.

Yet it is all about marketing muscle, and KOSP doesn't have it yet.

MIKE


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News